Philippe Morlat

7.0k total citations · 1 hit paper
109 papers, 4.2k citations indexed

About

Philippe Morlat is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Philippe Morlat has authored 109 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Infectious Diseases, 52 papers in Epidemiology and 35 papers in Emergency Medicine. Recurrent topics in Philippe Morlat's work include HIV-related health complications and treatments (35 papers), HIV/AIDS drug development and treatment (34 papers) and HIV/AIDS Research and Interventions (29 papers). Philippe Morlat is often cited by papers focused on HIV-related health complications and treatments (35 papers), HIV/AIDS drug development and treatment (34 papers) and HIV/AIDS Research and Interventions (29 papers). Philippe Morlat collaborates with scholars based in France, United States and Netherlands. Philippe Morlat's co-authors include Fabrice Bonnet, Geneviève Chêne, Dominique Costagliola, Thierry May, Charlotte Lewden, Éric Jougla, Dominique Salmon, P. Cacoub, Jens Lundgren and Lene Ryom and has published in prestigious journals such as The Lancet, PLoS ONE and Diabetes Care.

In The Last Decade

Philippe Morlat

106 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

2014 689 citations Colette Smith, Lene Ryom et al. The Lancet profile →

Peers

Countries citing papers authored by Philippe Morlat

Since Specialization

Citations

This map shows the geographic impact of Philippe Morlat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Morlat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Morlat more than expected).

Fields of papers citing papers by Philippe Morlat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Morlat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Morlat. The network helps show where Philippe Morlat may publish in the future.

Co-authorship network of co-authors of Philippe Morlat

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Morlat. A scholar is included among the top collaborators of Philippe Morlat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Morlat. Philippe Morlat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort) 2019 ·AIDS and Behavior ·(unknown), (unknown), Camélia Protopopescu, Philippe Sogni, Issifou Yaya, Lionel Piroth, François Bailly, Fabienne Marcellin, (unknown), Linda Wittkop, Éric Rosenthal, Philippe Morlat, Perrine Roux, Wildo Navegantes de Araújo, Dominique Salmon‐Céron, Patrizia Carrieri	13
2	Nontuberculous Mycobacterial Infections in a French Hospital: A 12-Year Retrospective Study 2016 ·PLoS ONE ·(unknown), H. Dutronc, Olivia Peuchant, Frédéric‐Antoine Dauchy, Charles Cazanave, D. Neau, (unknown), Jean‐Luc Pellegrin, Philippe Morlat, P. Mercié, (unknown), M.‐S. Doutre, (unknown), M. Dupon	27
3	Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study 2016 ·The Journal of Infectious Diseases ·Lene Ryom, Jens Lundgren, Mike Ross, Ole Kirk, Matthew Law, Philippe Morlat, Éric Fontas, Colette Smit, Christoph A. Fux, Camilla Ingrid Hatleberg, Stéphane De Wit, Caroline Sabin, Amanda Mocroft	39
4	HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients 2015 ·Journal of Clinical Virology ·Dominique Salmon, Firouzé Bani‐Sadr, Camille Gilbert, Éric Rosenthal, M.A. Valantin, Anne Simon, D. Neau, Philippe Morlat, (unknown), Linda Wittkop, François Dabis	1
5	Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration breakdown → 2014 ·The Lancet ·Colette Smith, Lene Ryom, Rainer Weber, Philippe Morlat, Christian Pradier, Peter Reiss, Justyna Kowalska, Stéphane De Wit, Matthew Law, Wafaa El‐Sadr, Ole Kirk, Nina Friis‐Møller, Antonella d’Arminio Monforte, Andrew Phillips, Caroline Sabin, Jens Lundgren	689
6	Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients 2014 ·BMC Infectious Diseases ·Nora Frulio, Hervé Trillaud, Paul Perez, Julien Asselineau, (unknown), Mojgan Hessamfar, Fabrice Bonnet, Florent Maire, (unknown), Victor de Lédinghen, Philippe Morlat	23
7	Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons 2013 ·AIDS ·Lene Ryom, Amanda Mocroft, Ole Kirk, Michael J. Ross, Peter Reiss, (unknown), Philippe Morlat, Olivier Moranne, Colette Smith, Wafaa El‐Sadr, Matthew Law, Jens Lundgren	58
8	Cognitive disorders in HIV-infected patients 2012 ·AIDS ·Fabrice Bonnet, Hélène Amieva, Fabienne Marquant, Charlotte Bernard, Mathias Bruyand, Frédéric‐Antoine Dauchy, P. Mercié, C. Greib, Laura Richert, D. Neau, Gwénaëlle Catheline, Patrick Dehail, François Dabis, Philippe Morlat, Jean‐François Dartigues, Geneviève Chêne	113
9	Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic) 2008 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Charlotte Lewden, Thierry May, Éric Rosenthal, Christine Burty, Fabrice Bonnet, Dominique Costagliola, Éric Jougla, Caroline Semaille, Philippe Morlat, Dominique Salmon, P. Cacoub, Geneviève Chêne	268
10	Number of deaths among HIV-infected adults in France in 2000, three-source capture–recapture estimation 2006 ·Epidemiology and Infection ·Charlotte Lewden, Éric Jougla, Ahmadou Alioum, G. Pavillon, (unknown), Philippe Morlat, Dominique Salmon, T. May, Geneviève Chêne, Dominique Costagliola	25
11	A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma 2006 ·Journal of Clinical Virology ·Fabrice Bonnet, (unknown), Marie Parrens, (unknown), (unknown), Isabelle Garrigue, Philippe Morlat, J Beylot, Hervé Fleury, Marie‐Edith Lafon	28
12	Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol 2005 ·Journal of Hepatology ·Dominique Salmon‐Céron, Charlotte Lewden, Philippe Morlat, S Bevilacqua, Éric Jougla, Fabrice Bonnet, Laurence Héripret, Dominique Costagliola, Thierry May, Geneviève Chêne	242
13	Malignancy‐related causes of death in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapy 2004 ·Cancer ·Fabrice Bonnet, Charlotte Lewden, Thierry May, Laurence Héripret, Éric Jougla, S Bevilacqua, Dominique Costagliola, Dominique Salmon, Geneviève Chêne, Philippe Morlat	159
14	Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237/ANRS 039 Study 2002 ·Clinical Infectious Diseases ·Keith Chirgwin, Richard Hafner, Catherine Leport, Jack S. Remington, Janet Andersen, (unknown), (unknown), Natasa Rajicic, Vincent McAuliffe, Philippe Morlat, (unknown), Jean‐Louis Vildé, Benjamin J. Luft	68
15	Sarcoïdose et comorbidité : étude rétrospective de 32 observations 2001 ·La Revue de Médecine Interne ·Fabrice Bonnet, (unknown), Philippe Morlat, X. Delbrel, M.‐S. Doutre, S Witte, N. Bernard, D. Lacoste, M. Longy‐Boursier, J Beylot	13
16	Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy 2001 ·Clinical Immunology ·Marianne Savès, Philippe Morlat, Geneviève Chêne, E. Peuchant, Isabelle Pellegrin, Fabrice Bonnet, N. Bernard, D. Lacoste, Roger Salamon, J Beylot	25
17	A possible association between Chlamydiae psittacci infection and temporal arteritis 2000 ·Joint Bone Spine ·Fabrice Bonnet, Philippe Morlat, I. Delèvaux, (unknown), Marie Parrens, N. Bernard, D. Lacoste, J Beylot	3
18	Thrombose de l'artère mésentérique supérieure et syndrome de Behçet 1996 ·La Revue de Médecine Interne ·P. Mercié, J. Constans, (unknown), A Sebban, George Gorin, Éric Rullier, Philippe Morlat, J Beylot, (unknown)	5
19	Toxoplasmose chez les patients immunodéprimés. Apport à la connaissance de l'infection toxoplasmique 1996 ·Médecine et Maladies Infectieuses ·C. Leport, Francis Derouin, Philippe Morlat, Geneviève Chêne, J. L. Vildé	6
20	La pneumocystose pulmonaire au cours du sida: analyse rétrospective de 80 cas documentés (1985–1993) 1996 ·La Revue de Médecine Interne ·Philippe Morlat, (unknown), (unknown), (unknown), D. Lacoste, (unknown), N. Bernard, P. Mercié, B. Couprie, J Beylot, J Aubertin	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact